Muscle: Excitation/Contraction Coupling Gordon Research Conference
Muscle: Excitation/Contraction Coupling Gordon Research Conference
批准号:
8254759
负责人:
Paul D Allen
金额:
$2.2万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-20 至 2012-08-31
关键词:
AffectAgeAgingAreaBasic ScienceCalciumCalcium SignalingCalsequestrinCardiacCellsCentral Core MyopathyClinical ResearchContractsCouplingDevelopmentDiseaseDisease ProgressionEnvironmentEuropeExerciseFatigueGoalsHealthHumanHypokalemic periodic paralysisInternationalKnowledgeLifeMalignant hyperpyrexia due to anesthesiaMeasuresMethodsMolecularMuscleMutationMyopathyNuclearParticipantProcessProteinsResearchResearch PersonnelRoleRyR1RyR2SERCA1ScientistSignal TransductionSiteSkeletal MuscleSwitzerlandTimeTimothy syndromeTranslational ResearchTriad Acrylic ResinVentricular Tachycardiabasecollegedisease-causing mutationexperiencehuman diseasemeetingsnovel strategiesrepairedresponseskeletalsymposium
中文摘要
描述(由申请人提供):戈登肌肉研究会议:兴奋-收缩耦合这是戈登研究会议(GRC)对骨骼肌兴奋-收缩耦合(ECC)的部分支持的提案,这是唯一一个专注于这一特定重点的国家或国际会议。2012年的会议将在欧洲瑞士Les diableets的GRC地点举行。钙信号在健康肌肉对运动的适应性反应中发挥着重要作用,而在ECC过程中,一些核心参与者的年龄突变导致肌肉疾病,如:1。低钾性周期性麻痹(骨骼l型Ca2+通道(DHPR))恶性高热(RyR1,骨骼DHPR)中央核病、多小核病和中核肌病(RyR1)。4. 布罗迪病(SERCA1)。5. 蒂莫西综合征(心脏DHPR)。和5。儿茶酚胺能多形性室性心动过速(RyR2和Calsequestrin 2)。了解导致这些疾病的机制的关键是了解受影响的蛋白质的正常功能。除了由参与ECC的蛋白质突变引起的肌肉疾病外,还有许多疾病是由不直接参与该过程的蛋白质突变引起的。然而,由于Ca2+信号的紊乱是引起肌肉损伤的病理级联反应的一部分,因此在ECC Gordon会议上讨论这些疾病有很大的好处。应对运动和衰老两者对人体健康都很重要。自2009年ECC Gordon会议以来,我们对肌肉中的兴奋-收缩耦合和其他类型的钙信号,以及钙在肌肉疾病、适应和修复中的作用的理解取得了重要进展。正是这一进展为我们规划2012年戈登ECC戈登会议提供了基础。我们相信,我们计划的会议将激励与会者在肌肉ECC,钙信号和疾病领域寻求新的方法和研究方向。
英文摘要
DESCRIPTION (provided by applicant): Gordon Research Conference on Muscle: Excitation-Contraction Coupling This is a proposal for partial support of the Gordon Research Conference (GRC) on Excitation-Contraction Coupling (ECC) in skeletal muscle, the only national or international meeting with this specific focus. The 2012 conference will be held in Europe at the GRC site in Les Diablerets, Switzerland. Calcium signaling figures importantly in the adaptive responses of healthy muscle to exercise and age mutations in a number central players in the ECC process cause muscle diseases such as: 1. hypokalemic periodic paralysis (skeletal L-type Ca2+ channel (DHPR)) 2. malignant hyperthermia (RyR1, skeletal DHPR) 3. central core disease, multi-mini core disease and centro-nuclear myopathy (RyR1). 4. Brody's disease (SERCA1). 5. Timothy syndrome (Cardiac DHPR). and 5. catecholaminergic polymorphic ventricular tachycardia (RyR2 and Calsequestrin 2). Key to understanding the mechanisms causing these diseases is understanding the affected protein's normal function. In addition to muscle diseases that result from mutations to the proteins that participate in ECC, there are many diseases that result from mutations to proteins that are not directly involved in this process. However, because a disturbance in Ca2+ signaling is part of a pathological cascade that causes muscle damage there is substantial benefit to having these diseases discussed in the ECC Gordon conference. in response to exercise and aging and both are important to human health. In the time since the 2009 ECC Gordon conference, there has been important progress in our understanding of excitation-contraction coupling and other types of calcium signaling in muscle, as well as of the role of calcium in muscle disease, adaptation and repair. It is this progress that provides the basis for our planning of the 2012 Gordon ECC Gordon Conference. We feel confident that the meeting we have planned will stimulate participants to pursue new approaches and research directions in the fields of muscle ECC, calcium signaling and disease.
PUBLIC HEALTH RELEVANCE: The goals of the 2012 Muscle: Excitation Contraction Coupling Gordon Research Conference are to discuss and evaluate critically new results related to the basic mechanisms that allow muscle to contract, and how these are affected by fatigue, age and mutations that cause muscle disease. This triennial conference is the only conference devoted to this very important area of medically relevant research and will allow participants who do basic, translational and clinical research to meet and discuss new ways to solve important problems affecting everyone's everyday life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms controlling Ca2+ dyshomeostasis in MH susceptible mice
-
批准号:9480595
-
项目类别:
-
资助金额:$23.76万
-
财政年份:2016
-
负责人:Paul D Allen
-
依托单位:
Mechanisms controlling Ca2+ dyshomeostasis in MH susceptible mice
-
批准号:10016079
-
项目类别:
-
资助金额:$23.76万
-
财政年份:2016
-
负责人:Paul D Allen
-
依托单位:
Integral membrane protein overexpression using organ bioreactors
-
批准号:7313034
-
项目类别:
-
资助金额:$20.09万
-
财政年份:2007
-
负责人:Paul D Allen
-
依托单位:
Administrative Core (Core A)
-
批准号:7489219
-
项目类别:
-
资助金额:$3.07万
-
财政年份:2007
-
负责人:Paul D Allen
-
依托单位:
Integral membrane protein overexpression using organ bioreactors
-
批准号:7493750
-
项目类别:
-
资助金额:$20.24万
-
财政年份:2007
-
负责人:Paul D Allen
-
依托单位:
Core B
-
批准号:7436120
-
项目类别:
-
资助金额:$8.7万
-
财政年份:2007
-
负责人:Paul D Allen
-
依托单位:
Integral membrane protein overexpression using organ bioreactors
-
批准号:7658832
-
项目类别:
-
资助金额:$20.24万
-
财政年份:2007
-
负责人:Paul D Allen
-
依托单位:
Heterozygous MH knock-in mice model Human MH susceptibility
-
批准号:7436116
-
项目类别:
-
资助金额:$21.91万
-
财政年份:2007
-
负责人:Paul D Allen
-
依托单位:
Uncovering the Molecular Basis of Malignant Hyperthermia
-
批准号:7223472
-
项目类别:
-
资助金额:$136.3万
-
财政年份:2006
-
负责人:Paul D Allen
-
依托单位:
Core B
-
批准号:7075000
-
项目类别:
-
资助金额:$21.12万
-
财政年份:2006
-
负责人:Paul D Allen
-
依托单位:
Uncovering the Molecular Basis of Malignant Hyperthermia
-
批准号:8478052
-
项目类别:
-
资助金额:$125.61万
-
财政年份:2006
-
负责人:Paul D Allen
-
依托单位:
Uncovering the Molecular Basis of Malignant Hyperthermia
-
批准号:7612017
-
项目类别:
-
资助金额:$133.59万
-
财政年份:2006
-
负责人:Paul D Allen
-
依托单位:
Murine Reagents
-
批准号:8667319
-
项目类别:
-
资助金额:$21.59万
-
财政年份:2006
-
负责人:Paul D Allen
-
依托单位:
The effects of MH mutations on muscle calcium homeostasis
-
批准号:8478053
-
项目类别:
-
资助金额:$24.59万
-
财政年份:2006
-
负责人:Paul D Allen
-
依托单位:
Murine Reagents
-
批准号:8478058
-
项目类别:
-
资助金额:$21.02万
-
财政年份:2006
-
负责人:Paul D Allen
-
依托单位:
Murine Reagents
-
批准号:8337938
-
项目类别:
-
资助金额:$60.63万
-
财政年份:2006
-
负责人:Paul D Allen
-
依托单位:
Uncovering the Molecular Basis of Malignant Hyperthermia
-
批准号:8269217
-
项目类别:
-
资助金额:$137.17万
-
财政年份:2006
-
负责人:Paul D Allen
-
依托单位:
The effects of MH mutations on muscle calcium homeostasis
-
批准号:8858508
-
项目类别:
-
资助金额:$26.18万
-
财政年份:2006
-
负责人:Paul D Allen
-
依托单位:
Uncovering the Molecular Basis of Malignant Hyperthermia
-
批准号:7074449
-
项目类别:
-
资助金额:$150.34万
-
财政年份:2006
-
负责人:Paul D Allen
-
依托单位:
Sub-Project #1
-
批准号:7075002
-
项目类别:
-
资助金额:$29.11万
-
财政年份:2006
-
负责人:Paul D Allen
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: